Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy
By Carole Tanzer Miller HealthDay Reporter
TUESDAY, Oct. 1, 2024 -- Blood cancer patients of all races who receive cord blood transplants are now living longer.
The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously identified survival gap for transplant recipients has been eliminated.
"Outcomes for cord blood transplants are improving for patients of all racial and ethnic backgrounds," Ballen said in a UVA news release.
The new study looked at more than 2,600 patients with blood cancer who received umbilical cord blood transplants between 2007 and 2017.
Black, Asian, Hispanic and white recipients survived equally well, the study found.
Still, cases of "graft-versus-host" disease -- a complication of cord blood transplantation that can lead to organ damage and severe infections -- was more common in Black children.
Cord blood cells restore the patient's ability to make blood cells after such cancer treatments as high-dose chemotherapy.
Though cord blood transplants are becoming less common in the United States, researchers said cord blood remains a vital lifeline for many patients. Because it needs not be precisely matched to the recipient, it is especially helpful for patients from racial or ethnic minority groups who often struggle to find a fully matched unrelated donor.
Researchers found that matching race was less important than the total number of cord blood cells transplanted.
"The more, the better," they said.
They cited several contributors to improved survival rates. Those included improved identification of appropriate patients, newer techniques for matching patients and donors, and better antibiotics and other care.
The findings are published in the October issue of the journal Transplantation and Cellular Therapy.
Sources
- UVA Health, news release, Sept. 30, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Recalled: More Than 67,000 Cases of Deodorant Sold at Dollar Tree, Walmart, and Amazon
TUESDAY, July 22, 2025 — More than 67,000 cases of Power Stick deodorant have been recalled due to an undisclosed manufacturing issue. The recalled deodorants, made by A.P...
Dogs Can Sniff Out Parkinson's Disease, Study Shows
TUESDAY, July 22, 2025 — Dogs’ noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect illicit drug...
For Some, Gluten Intolerance Is Psychological, Study Says
TUESDAY, July 22, 2025 — Gluten intolerance might be all in the minds of some people with irritable bowel syndrome (IBS), results from a small-scale experiment...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.